Management is buying the same thing twice: proven demand from one place is being replicated into identified new places r
The model's full reasoning — Q2 2023 call → NOThe question asks whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is already visible. Let me analyze the transcript carefully. Key elements needed: 1. A PROVEN INSTANCE THAT ALREADY WORKS - something concrete that has demonstrably performed 2. COPIES ARE PHYSICALLY BEING STOOD UP NOW - additional instances being built/opened now 3. DEMAND IS ALREADY IDENTIFIED AT THE DESTINATION - demand already visible at the new locations Let me look at what management discusses: - They discuss clinic operations, productivity improvements, centralized intake rollout - They mention opening 6 new clinics in higher-growth markets during the quarter - They closed 4 underperforming clinics - They discuss the centralized intake support platform rollout - "We are about 60% of the way through rolling out our modernized and centralized intake support platform across all 900 plus clinics" - They discuss revenue cycle management improvements Let me examine the centralized intake rollout more carefully. Chris Cox says: "We are about 60% of the way through rolling out our modernized and centralized intake support platform across all 900 plus clinics. And we are seeing providers in those markets that are already supported by this model able to spend more time operating at the top of their license, focusing on patients and delivering high quality evidence-based care." So the centralized intake platform has been proven in some markets (60% rolled out), and they're continuing to roll it out to the remaining 40% of clinics. This could be seen as a proven instance being copied to additional places. But is demand already identified at the destination? The demand here would be for the centralized intake services at the remaining clinics. The demand is internal - the clinics need this support. But is this "demand already visible at the destination"? The clinics are already there, and the need is evident. However, let me think about whether this fits the criteria. The centralized intake is a support function, not really a "business" being replicated. It's more of an operational improvement being rolled out. Now let me look at the clinic openings: "we opened six new clinics in higher-growth markets during the quarter." This is about opening new clinics.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| VSEC | VSE Corporation | Q3 2022 | 2022-10-28 | B+ |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| TPIC | TPI Composites, Inc. | Q3 2018 | 2018-11-11 | C |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOLD | Amicus Therapeutics, Inc. | Q1 2018 | 2018-05-08 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| VSAT | Viasat, Inc. | Q4 2017 | 2017-05-23 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GDS · Q2 2021 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a clear, present-tense replication of their proven China-based data center platform into new markets (Hong Kong, Macau, Southeast Asia) where demand is already visible and committed. William Huang explicitly references the “proven” China edge-of-town model (land-and-expand MOUs, 500 000 sqm secured pipeline, hyperscale orders already landed) and states they are “currently developing two purpose-built data centers” in Hong Kong (HK1/HK2) with most capacity “already allocated to strategic customers pending contracts,” plus a new building (HK4) under agreement and a heads-of-agreement for HK3, creating “nearly 80 megawatts of purpose-built capacity through to 2027.” For Macau they have a JV to acquire brownfield sites for redevelopment (20 MW).
FOLD · Q1 2018 → YESThe question is about whether management describes the company as currently copying a proven part of its business into additional places where demand is already visible. YES The transcript shows management describing Galafold as a proven commercial offering (Q1 revenue $16.7M, 300% YoY growth, hundreds of patients, high compliance, 7 approvals, 18 countries with pricing/reimbursement) that is now being replicated into additional markets.
TPIC · Q3 2018 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a proven manufacturing operation (existing dedicated lines and plants in the U.S.